Adult Disease
23
2
4
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.7%
2 terminated out of 23 trials
88.2%
+1.7% vs benchmark
4%
1 trials in Phase 3/4
7%
1 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (23)
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors
Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).
Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients
Relationship of the Physical Activity Practice and Its Different Domains With Cardiac Autonomic Modulation
A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.
Human Phenotype Project Study Protocol
Effectiveness of Bio-Healthy Park on Adult
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients
Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University
Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W
The Effect and Safety of the Four Points Transversus Abdominis Plane Block
HMGB1 Release From Hemorrhagic Shock Patients
Applying a Stress Framework to Health Behavior Change: A Fitbit Study
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior